RNASET2
Basic information
Region (hg38): 6:166922113-166957191
Links
Phenotypes
GenCC
Source:
- cystic leukoencephalopathy without megalencephaly (Definitive), mode of inheritance: AR
- cystic leukoencephalopathy without megalencephaly (Strong), mode of inheritance: AR
- cystic leukoencephalopathy without megalencephaly (Strong), mode of inheritance: AR
- cystic leukoencephalopathy without megalencephaly (Supportive), mode of inheritance: AR
- cystic leukoencephalopathy without megalencephaly (Moderate), mode of inheritance: AR
- cystic leukoencephalopathy without megalencephaly (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Leukoencephalopathy, cystic, without megalencephaly | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may possibly benefit developmental outcomes in some individuals, including speech and language development | Audiologic/Otolaryngologic; Neurologic | 9810556; 11589166; 15851732; 19525954 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (106 variants)
- Cystic_leukoencephalopathy_without_megalencephaly (43 variants)
- Inborn_genetic_diseases (26 variants)
- RNASET2-related_disorder (7 variants)
- not_specified (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNASET2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003730.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 33 | 38 | ||||
| missense | 52 | 62 | ||||
| nonsense | 3 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 6 | |||||
| Total | 9 | 3 | 55 | 40 | 6 |
Highest pathogenic variant AF is 0.0016803306
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RNASET2 | protein_coding | protein_coding | ENST00000508775 | 9 | 27688 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000269 | 0.938 | 125730 | 0 | 18 | 125748 | 0.0000716 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.243 | 133 | 141 | 0.942 | 0.00000748 | 1670 |
| Missense in Polyphen | 36 | 45.915 | 0.78405 | 596 | ||
| Synonymous | -0.445 | 62 | 57.7 | 1.07 | 0.00000361 | 463 |
| Loss of Function | 1.68 | 8 | 15.0 | 0.533 | 6.41e-7 | 168 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000290 | 0.0000290 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000139 | 0.000132 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has ribonuclease activity, with higher activity at acidic pH. Probably is involved in lysosomal degradation of ribosomal RNA (By similarity). Probably plays a role in cellular RNA catabolism. {ECO:0000250, ECO:0000269|PubMed:16620762, ECO:0000269|PubMed:19525954, ECO:0000269|PubMed:22735700}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.546
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.38
Haploinsufficiency Scores
- pHI
- 0.0792
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.451
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.217
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnaset2b
- Phenotype
- renal/urinary system phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- rnaset2
- Affected structure
- CNS neuron (sensu Vertebrata)
- Phenotype tag
- abnormal
- Phenotype quality
- increased size
Gene ontology
- Biological process
- RNA catabolic process;neutrophil degranulation;RNA phosphodiester bond hydrolysis, endonucleolytic
- Cellular component
- extracellular region;extracellular space;lysosome;endoplasmic reticulum lumen;azurophil granule lumen;lysosomal lumen;extracellular exosome
- Molecular function
- RNA binding;endoribonuclease activity;ribonuclease activity;ribonuclease T2 activity